Revive Therapeutics (unofficial)

Revive Therapeutics (unofficial). Telling the story of Revive Therapeutics: Psychedelics, CBD, Covid-19 Oral Therapeutics - Bucillamine

[KAMTRADER ™️ @kamtraders]

A lot of research from Washington and Providence … 🤔 👇

Something coming guys …

Revive Therapeutics $RVV $RVVTF
@Revive_RVV

[KAMTRADER ™️ @kamtraders]

REVIVE THERAPEUTICS $RVV $RVVTF

Potential value:
Canadian program only :$20M - $100M
NATO / Five Eyes
stockpiling:$100M - $500M
+ Broad adoption for chemical defense: $1B+

$PF $JNJ $MRNA $VERU

[KAMTRADER ™️ @kamtraders]

What also needs to be considered is that if Revive Therapeutics $RVV $RVVTF secures a government contract, it opens the door to all the other studies that are stalled due to lack of funding.

Therefore, Revive's potential for commercialization is greater than just a contract with the DRDC… We have long COVID, influenza, cancer, etc…

[KAMTRADER ™️ @kamtraders]

REVIVE THERAPEUTICS $RVV $RVVTF

DRDC is evaluating pharmacological compounds, including Bucillamine, that may mitigate nerve agent–induced brain injury.

MedicalCountermeasures(gov), explains its purpose, and explores how it supports preparedness, response, and protection of public health during emergencies.

$PF $JNJ $MRNA $VERU

https://t.co/uRoYB7TDNC

[KAMTRADER ™️ @kamtraders]

😍👇 $RVV $RVVTF

[Randylus @randylus]

$RVVTF | Golden Cross | New 52WK High
Revive Therapeutics Ltd.

[Randylus @randylus]

$RVVTF
Revive Therapeutics is a life sciences company focused on the research and development of therapeutics and diagnostics for infectious diseases and rare disorders...

[Randylus @randylus]

$RVVTF

[KAMTRADER ™️ @kamtraders]

REVIVE THERAPEUTICS on the move 🆙
$RVV $RVVTF

$jnj $pf $mrna $veru

[KAMTRADER ™️ @kamtraders]

Time to vote $RVV $RVVTF 👇

[Randylus @randylus]

$RVVTF

[KAMTRADER ™️ @kamtraders]

HUGE OPPORTUNITY WITH REVIVE THERAPEUTICS $RVV $RVVTF 👇

[Revive Therapeutics (CSE: RVV, US: RVVTF) Official @Revive_RVV]

Revive Therapeutics Announces Strategic Focus on Bucillamine for Infectious Diseases and Medical Countermeasures

https://t.co/k4yAXa4dtV

$RVV $RVVTF #Bucillamine #InfectiousDiseases #MedicalCountermeasures #RareDisorders #NerveAgent #DRDC #DefenceRDC #FDA #HealthCanada #monkeypox

[Revive Therapeutics (CSE: RVV, US: RVVTF) Official @Revive_RVV]

Revive Therapeutics Nears Completion of Key Nerve Agent Countermeasure Study with Canadian Department of National Defence Highlighting Significant Stockpiling Opportunity

https://t.co/wf9v14RgaK

$RVV $RVVTF #Biotech #Research #HealthCare #Bucillamine #InfectiousDiseases #Pharmaceuticals #DrugDevelopment #DRDC #Braininjury

[Revive Therapeutics (unofficial) @revivethera]

One thing to remember is that there aren't human trials for nerve agent exposure because it would be unethical. #Bucillamine 's safety record means it would go from positive results to @GovCanHealth Health Canada and @US_FDA approval in fairly quick succession.

[Revive Therapeutics (unofficial) @revivethera]

$RVV is up 366% in the last 5 days. If #DRDC releases positive data we'll jump up significantly.

[Revive Therapeutics (CSE: RVV, US: RVVTF) Official @Revive_RVV]

Revive Therapeutics Strengthens Bucillamine IP Portfolio

Revive Therapeutics expands its #Bucillamine IP with new North American patent filings for nerve agent exposure and a granted Canadian patent for infectious diseases.

https://t.co/w7kuVPQX34

$RVV $RVVTF #Biotech #Research #HealthCare #Bucillamine #InfectiousDiseases #Pharmaceuticals #DrugDevelopment #ReviveTherapeutics #MedicalCountermeasures

[KAMTRADER ™️ @kamtraders]

ALERT VOLUME 🔝2M +
12X volume average 😍

Revive Therapeutics
(OTCQB: $RVVTF) (CSE: $RVV)

Intellectual property 👇
Market cap : $10 millions

$jnj $mrna $veru $tspt $pfe #biotech #Bucillamine #Covid #LongCovid #Mpox #psychedelic #weed @RobertKennedyJr @US_FDA

[KAMTRADER ™️ @kamtraders]

POSSIBLE BREAKOUT OUT 📈

Revive Therapeutics
(OTCQB: $RVVTF) (CSE: $RVV)

Revive is strategically positioning New Bucillamine to target public health emergencies such as pandemic influenza and emerging infectious diseases.

$jnj $mrna $veru $tspt $pfe #biotech #Bucillamine #Covid #LongCovid #Mpox #psychedelic #weed @RobertKennedyJr @US_FDA

[KAMTRADER ™️ @kamtraders]

Revive Therapeutics (OTCQB: $RVVTF) (CSE: $RVV)

Company has been contacted by a prominent clinical researcher from a U.S. University Cancer Institute to investigate Bucillamine for boosting anti-tumor effects in patients with advanced solid tumors, potentially opening up another significant market segment.

$jnj $mrna $veru $tspt $pfe #biotech #Bucillamine #Covid #LongCovid #Mpox #psychedelic #weed @RobertKennedyJr @US_FDA